The COVID-19 pandemic is seriously affecting the sleep habits of half of those surveyed in a new study from The Royal and the University of Ottawa, leading to further stress and anxiety plus further dependence on sleep medication.
A new study offers strong evidence that kids who use e-cigarettes are more likely to take up smoking or smokeless tobacco, researchers say. Teen boys who vaped were almost three times as likely to start smoking as other teen boys with similar risk profiles and more than two times as likely to try smokeless tobacco, the study from The Ohio State University found.
Having hope for the future could protect people from risky behaviours such as drinking and gambling - according to new research from the University of East Anglia.
Study finds no decrease in prescription fills or clinician visits in the first three months of the COVID-19 pandemic for patients recently receiving opioid use disorder therapy. On the flip side, the study found that during this period fewer people started new treatment for opioid use disorder and fewer urine tests were given across both new and established patients. Findings identify strengths and weaknesses in telemedicine’s role for opioid use disorder during shutdowns and can inform strategies for improvement.
A community or sub-culture encouraging young men's exposure and obsession with guns - as well as ready access to firearms and drugs - can make gun violence 'all too easy', with Flinders University experts promoting a new direction on managing the global problem.
The opioid epidemic has only gotten worse since the advent of COVID-19, with some areas in the U.S. reporting a 50% increase in drug overdoses due to the pandemic. With no end in sight to this public health crisis, scientific sessions during the virtual 2020 AACC Annual Scientific Meeting & Clinical Lab Expo will highlight the integral role of clinical laboratories in efforts to manage it, as well as the latest drug tests needed to do so.
New research has shown robots can encourage people to take greater risks in a simulated gambling scenario than they would if there was nothing to influence their behaviours.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed a series of case studies for urgent public health issues to help students and practitioners across the U.S. learn how to apply big-data analysis approaches in their work.
Cocaine continues to be one of the most commonly abused illicit drugs in the United States. Pre-clinical literature suggests that targeting glucagon-like peptide-1 receptors (GLP-1Rs) in the brain may represent a novel approach to treating cocaine use disorder. Specifically, GLP-1R agonists, which are FDA-approved for treating diabetes and obesity, have been shown to reduce voluntary drug taking and seeking in preclinical models of cocaine used disorder. However, the exact neural circuits and cell types that mediate the suppressive effects of GLP-1R agonists on cocaine-seeking behavior are mostly unknown.
Research from Saint Louis University finds that among patients at risk for opioid misuse, the odds of receiving a schedule II opioid for non-cancer pain were similar to those not at risk, despite new prescribing guidelines from the Centers for Disease Control (CDC).
Brexit offers the UK opportunities to strengthen its world-leading tobacco control measures, by creating greater flexibility to respond to industry action and market developments, according to new research from the University of Bath.
Young adults who combine alcohol and cannabis use experience fewer negative consequences when they stick with a single type of drink versus consuming multiple types of alcohol, according to a new study. In addition, by avoiding cannabis concentrate they may steady or lower their overall consumption. The findings suggest that for those who choose to sustain their levels of alcohol and cannabis use, judicious choice of products may reduce the risks.
Giving nurse practitioners the authority to prescribe buprenorphine has brought that gold standard treatment for opioid addiction to people who might not have had access to it before, according to a new study led by Tracy Klein, PhD, associate professor at the Washington State University College of Nursing in Vancouver.
UCLA has received seven grants totaling $6.4 million from the California Bureau of Cannabis Control. The awards will fund studies on topics ranging from the toxicity of inhaled and second-hand cannabis smoke to employment conditions in California’s cannabis industry.
ore than 1.1 million Medicare patients could die over the next decade because they cannot afford to pay for their prescription medications, according to a new study released today by the West Health Policy Center, a nonprofit and nonpartisan policy research group and Xcenda, the research arm of the drug distributor AmerisourceBergen.
Before the COVID-19 pandemic, information about the dangers of vaping was emerging. To investigate the potentially serious health and respiratory implications of vaping, Mayo Clinic researchers wanted to better understand the factors influencing vaping in the community.
With support from a nearly $340,000 grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), Ian Mendez, Ph.D., UTEP assistant professor of pharmacy, is developing an animal model that mimics real life exposure to e-cigarettes in order to investigate the effects of nicotine vapor exposure on adolescent behavior.
Scientists and medical professionals have long debated whether pod e-cigarettes are a safer alternative to traditional cigarettes. A new study provides some insight.
New research shows that over the past 50 years street cannabis across the world has become substantially stronger carrying an increased risk of harm.
Dr. Lorraine Kelley-Quon forms team of health care providers and community advocates to establish recommendations for safe opioid use. According to the National Institutes of Health, opioid misuse and addiction in the United States is a national crisis, with an economic burden upwards of $78 billion. Opioids are useful for pain management following surgery and other major procedures, but until now there have been no recommendations guiding safe use of opioids in children.
A Rutgers expert discusses the many impacts of COVID-19 on people with substance use disorder and what treatment providers, policymakers and researchers are doing to help.
Both fatal and nonfatal overdoses have increased this year compared to last, according to a recent report by the Overdose Data Mapping Application Program. And, anecdotal information suggests that compared to last year, people in recovery are relapsing at alarming rates.
November 19, 2020 marks the Great American Smokeout, an annual intervention hosted by the American Cancer Society as a call to action to take the first step towards better health through the elimination of tobacco products. Rutgers experts share more on why and how to get started.
An epidemic that was already raging before COVID-19 arrived has flared up in recent months, according to a real-time tracking system in Michigan. It shows a 15 percent rise in suspected opioid overdose deaths since March, compared with the same time last year, and a 29% rise in first responders’ use of the rescue drug naloxone.
A new study suggests that patients with opioid use disorder may be identified using information available in electronic health records, even when diagnostic codes do not reflect this diagnosis. The study demonstrates the utility of proxies coding for DSM-5 criteria from medical records to generate a quantitative DSM-5 score that is associated with opioid use disorder severity. The study methods are unique in deriving a severity score that aims to mirror severity scores from more traditional interview-based diagnostic procedures.
Nearly one-third of students who reported misusing prescription opioids as high school seniors between 1997 and 2000, but did not have a history of medical use, later used heroin by age 35, according to a University of Michigan study.
Highlights from AJPH December Issue
The Mexico Violence Resource Project—a new initiative from the University of California San Diego’s Center for U.S.-Mexican Studies—was recently launched to provide policymakers and journalists analysis and information to better understand the complicated escalation of violence in Mexico.
In the wake of the opioid addiction crisis that has cost more than 500,000 U.S. lives, medical investigators have focused on finding new methods to help patients control pain.
A new IU study examining effects of low-level developmental lead exposure in mice could explain why some people dependent on alcohol return to using.
Almost 20 years into the opioid epidemic, there finally is evidence of significant and continual decreases in the abuse of these risky pain medications, according to an analysis of national data being presented at the ANESTHESIOLOGY® 2020 annual meeting.
The NIH has awarded NYU College of Dentistry researchers Nigel Bunnett, PhD, and Brian Schmidt, DDS, MD, PhD, a $3.9 million grant to study targeting endosomal receptors for the treatment of chronic pain. The five-year grant will support Bunnett and Schmidt’s collaborative research, which aims to ultimately yield improved pain management without the need for opioids.
College students with physical and cognitive disabilities use illicit drugs more, and have a higher prevalence of drug use disorder, than their non-disabled peers, according to a Rutgers study.
Opioid use disorder and overdose have reached unprecedented levels around the world. In the United States, remediation of pain is one of the most common reasons American adults seek healthcare. Therefore, it is vital that clinicians practicing in diverse roles and settings have a clinical understanding of pain and substance use disorders as well as knowledge about public health and opioid policy interventions.
Scientists at Sanford Burnham Prebys Medical Discovery Institute, Camino Pharma, LLC and University of California San Diego School of Medicine have been awarded an $11.4 million grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) to advance a novel drug candidate for nicotine addiction into first-in-human Phase 1 studies. The drug targets a neuronal signaling pathway underlying addictive behaviors, and would be a first-in-class medication to help people quit smoking.
The slight decline in drug overdose deaths in 2018 coincides with Chinese regulations on the powerful opioid carfentanil, rather than the result of domestic U.S. efforts to curb the opioid epidemic, a University of Pittsburgh Graduate School of Public Health analysis revealed today.
The University of Texas at El Paso’s Minority AIDS Research Center (MARC) is the subrecipient of a $1 million implementation grant to target substance use disorders and opioid use disorders in five rural counties along the Texas-Mexico border.
Traditionally, primary care clinics connect patients who have mental health care needs to specialists like psychiatrists in a collaborative care model.
Abandoned Buildings, Fear of Calling Police Contribute to High Rate of Fatal Overdoses in Philadelphia, New Study Shows
The United States has seen a 200% increase in the rate of deaths by opioid overdose in the last 20 years. But many of these deaths were preventable. Naloxone, also called Narcan, is a prescription drug that reverses opioid overdoses, and in more than 40 states — including Pennsylvania — there is a standing order policy, which makes it available to anyone, without an individual prescription from a healthcare provider.
Luis M. Tuesta, Ph.D., assistant professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami Miller School of Medicine, has been awarded the Avenir Award from the National Institute on Drug Abuse, part of the National Institutes of Health, to study the epigenetic mechanisms of microglial activation and their role in shaping the behavioral course of opioid use disorder.
Most doctors misperceive the risks of nicotine, the addictive chemical in tobacco products, according to a Rutgers-led national survey.
To better understand the effect of the COVID-19 pandemic on cannabis and CBD use, the UCLA Cannabis Research Initiative has launched the Cannabis, CBD and COVID Survey.
Two UC San Diego School of Medicine-led analyses report that e-cigarettes are not effective in helping adults to quit smoking.
Brief interventions can potentially reduce incarcerated women’s alcohol use when they leave jail, according to a new study.
New study findings in mice suggest that repeated binge drinking increases the motivation to consume alcohol to excess. In humans, the pattern of drinking (as well as quantity consumed) can be an important indicator of future drink problems; in adolescents, for example, a binge-drinking pattern can predict development of alcohol use disorder (AUD). Studies using laboratory animals that have been selectively bred to drink alcohol (ethanol) in large amounts can provide valuable insights on problematic drinking patterns, using experimental approaches that would be impossible or unethical to apply in humans. Indeed, many important findings on responses to alcohol have been gained from animal studies, conducted to strict welfare guidelines. The latest study, reported in Alcoholism: Clinical and Experimental Research, examined two behaviors in mice that reflect their motivation to experience alcohol’s rewarding effects on the brain.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right